Our results revealed that SIRT1 expression, as determined by either western blot analysis or IHC, correlated with tumor progression and was an independent predictor of a poor prognosis in gastric cancer patients, which were in agreement with previously reported findings [15, 25]. Here, SIRT1 is linked to neoplasm.